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Abstract
Gabriel Richet was one of the great pioneers of European Nephrology. After a pivotal period of work with Jean
Hamburger, whom we owe the name of our discipline, Nephrology, he contributed to all aspects of this specialty
and was, in particular, a forerunner in dialysis and in the study of interstitial nephropathies.
In this passionate and lucid interview, recorded in Paris in 2010, he describes himself as a “lucky man”, able to
transform folly in happiness. He does not describe himself as an intellectual, but as a warrior, and closes a detailed
history of the early days of European Nephrology with a strong statement of the moral stature a physician should
have: he underlines, in line with his strong personality, that a physician is a man able to decide, to give orders and
to assume their consequences. However, science and care of human beings cannot exist without a heart. “A doctor
is someone who decides; when he writes a prescription, this means he prescribes and takes responsibility. Is it
possible to give a prescription and decide regardless of compassion?”. In his interview, he commented that this last
statement is probably not uniformly agreed, but that he’ll always defend it, adds freedom as a moral value that a
physician should proudly defend: “Unfortunately I know that many do not share my idea, but that’s life... I am like
the Queen of Holland, whose motto is: I will maintain!”.
Introduction
The series dedicated to the pioneers of the European
Nephrology opens with the words of the pioneer of the pi-
oneers, Gabriel Richet, interviewed in Paris in 2010.
Since no written English translation can account for
the elegance of his irony or the intensity of his blue eyes,
we invite you to listen to the full interview, of which we
have selected sections that, in our opinion, better convey
the heroic character of the lucky, sometimes a wild man,
as he describes himself, in this passionate interview,
reconstructing through enlightening anecdotes his per-
sonal history along with the history of Nephrology [1]
(Fig. 1).
Professor Gabriel Richet: An interview
I’m a man who always had a lot of luck. I did a lot
of silly things, and generally, their results have been
quite good. That’s about it. I was very bold during
the war in 39–40 and in 44–45 and also the time in
between, but this was a bit different. I was injured, a
bullet entered the top of my right thigh and was
found against the left femoral artery, 60 cm of
stitches and 60 days later, I went back to the front
line. That is to say that I have a rather adventurous
character.
Medicine? I don’t know why but I was a senior in high
school; I was 16, I was bored during the correction of a
Latin translation, I decided that I would study medicine, a
Tuesday morning in February 1933. Of course, there was
the weight of my name, my grandfather who had been
awarded the Nobel Prize for Medicine for having discov-
ered anaphylaxis ... he had twenty grandchildren, and I’m
the only one to have studied medicine. My father and my
mother, they were both physicians, my father was a profes-
sor at La Pitié hospital ...
This is the past onerous burden that made things eas-
ier for me, but which weighed heavily on my behaviour.
... There is nothing to do, yet you can do everything,
try everything ... You can’t get rid of your ancestors. My
father and mother were both doctors, they had six chil-
dren and I’m the only one to have studied medicine. I
think since my birth it was written; it could only be that.
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Nephrology? I engaged myself when I was a resident of
Pasteur Vallery-Radot, at Broussais hospital. I was not too
happy there, and I enthusiastically followed Jean Hambur-
ger in 1951, for a specialty that did not exist yet. Why do
you want to have a specialty when there is no treatment?
Clinical nephrology was born, and well-born, when
there were mavericks who invested in the treatment
of acute uremia, but they made mistakes; they put
all their efforts in chronic uremia where there was
no hope.
Look at the first work of the Dutch Kolff which ap-
peared in French in the “Presse Medicale” in April 1944;
he put in his dialysis solution just water and sodium chlor-
ide. Potassium?... Did not know...! Acid-base? Did not
know...! But he and Alwall in Sweden built the first dia-
lyzers without taking into account the initial electrolyte
content of the blood which was perfectly known for a long
while. This mistake made us rediscover the notion of the
milieu interieur (internal environment) of Claude Bernard
and other authors. Henri Roger, Dean of the School of
Medicine in Paris in 1925, used to say “Medicine, in par-
ticular, is a science that progresses by correcting mistakes
more than by great discoveries.”
Medicine is made to cure diseases, so if you find some-
thing that you can’t use for healing, it could be very inter-
esting, but you must go to the Faculty of Literature of
Paris. But if you want to heal, you have to know the bio-
logical basics to conduct an intelligent therapy.
When we arrived with Jean Hamburger at Necker Hos-
pital in January 1951, we didn’t know, and sometimes we
didn’t want to know that urea and other nitrogenous
waste products were not a direct cause of death, but the
cause of death was the retention of potassium very nicely
demonstrated by the work of Feltz and Ritter in 1881.
You’ve probably never heard of these two people; you’ve
probably never read their 300-page book ... but I must
continue my education and yours at the same time!
And why has potassium been discovered? Because there
were portable electrocardiographs… Suddenly, after the
war, there were portable electrocardiogram machines with
Fig. 1 Gabriel Richet in his home in Paris in 2010. Photos by Gilberto Richiero
Fig. 2 Gabriel Richet in his home in Paris in 2010. Photos by Gilberto Richiero
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direct printing at the patients’ bedside. Once the peaked T
wave of hyperkalemia was recognized, the treatment of
AKI was transformed.
So this is to say that, first, it’s necessary to be specialized
and secondly, it’s necessary to have a very open mind.
How do you keep an open mind? Well, it’s extremely sim-
ple, it’s by examining your patients and with the idea of
looking relentlessly for surprising facts.
The right to astonish oneself, the duty to astonish one-
self, to find an anomaly in the reasoning process, a rea-
soning accepted by everyone else … by thinking outside
of the box ...
I think this idea is still present in our specialty, and
when our specialty evolves, we must have the courage,
which I did not have, to abandon all your knowledge, in
order to solve the unresolved issues …. One has to make
the right choice at the right time to resolve the problem.
I remember one of my bosses whose name I will
not mention ... When I started to practice in ‘45,
returning from the war, we were all practicing
internal medicine, and there were older persons with
back pain who were given large doses of vitamin D,
and it worked. My boss told me: “I administered it,
but I do not know how it works, but empirically, it
works” and then we learned that these patients had
uremic osteopathy with all that it entails, and the kid-
ney was an organ that transformed vitamin D ...
As you know, the whole Paris school focused on acute
uremia, once we understood that it interposed itself be-
tween the severe infection and death, but it could be re-
solved like some rare cases of toxic uremia.
The experience with acute uremia was encouraging ...
patients could be cured and not dying because we could
not keep them alive for two weeks, because we could not
control their biochemical disorders. And that is something
that is very important because it changed the way of
thinking, broadening it beyond nephrology, as we shall see
later.
The first attempt which was made in France in
1947 was successful; it was the exchange transfusion,
Fig. 3 Gabriel Richet in his home in Paris in 2010. Photos by Gilberto Richiero
Fig. 4 Gabriel Richet in his home in Paris in 2010. Photos by Gilberto Richiero
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seven or eight liters of blood, and this was due to
the work of Paul Milliez in the service of Pasteur
Vallery Radot. He succeeded him one decade later.
This method did not last because there were difficul-
ties in obtaining enough liters of blood, we only
knew the Rh factor apart from other major blood
groups … but also its efficacy was mediocre.
The second attempt was made at the Necker Hospital.
It was the intestinal infusion by a naso-jejunal probe
with evacuation by natural routes.
There was a patient whom I remember. She came
to Necker on June 6th, 1951. She was a mother of
four children, her last child was born a few days earl-
ier, and she developed a severe pelvic infection that
was successfully treated with penicillin, but she
remained anuric. But then we were doubly lucky: she
was a robust peasant, I would say like a Verdun sol-
dier or the equivalent (…). We gave her an infusion
probe. After 24 h, she couldn’t stand the probe any
longer and she ripped it out. Her husband came to
see her at the end of the morning, and Professor
Hamburger told him: “We’re sorry, but your wife just
ripped out her probe and it was her only chance of
survival”. Her husband answered: “Fine”, went to see
his wife who was nearby, and said (…) “You have cost
me a lot of money in ambulance and transport fees
to come to Paris from Loir-et-Cher, and then you rip
out your probe, what am I going to do with our four
kids?” (…). After this, she kept her infusion probe for
11 days, and she recovered.
I can tell you that this case study, which we pub-
lished in the Société Médicale des Hôpitaux, taught
us all about spontaneously reversible acute kidney
injury...
Not only this technic kept her alive, but it kept alive a
mother for her children, a wife for her husband, whose
strength she admired. She served as a reference for future
cases.
Then there was peritoneal dialysis. The first peri-
toneal dialysis, I don’t know where they happened,
but in France, they began in ‘47 with Pierre Tanret at
Hotel Dieu hospital who tried peritoneal dialysis, it
was an amazing DIY [Do It Yourself]...
They were very complicated treatments: intestinal
dialysis, peritoneal dialysis, and artificial kidney. We
went from biology to very simple physico-chemical
laws: it was called dialysis, described in 1825 by
Dutrochet. It was famous, but it was forgotten...
We forgot that there were people who worked before
the end of the Second World War.
I’ll tell you what happened to me. In the United States,
the artificial kidney has benefited from the work of a per-
son who had done a great job, Merrill in Boston, who in
1952 published an excellent article in “Medicine” about it.
But everywhere else, nobody cared about dialysis, every-
one, or almost everyone, thought that conservative man-
agement was the only one that could work ….
Well, I was in New York in ‘54, and a senior told me:
“Why the hell did you go to Boston to learn the handling
of the Kolff Merrill artificial kidney, while in New York we
don't need it?...” They told me that in 1954, but why? Be-
cause patients were treated in internal medicine, where
they saw a case of anuria every six months, while Merrill
used to accept all the anuric patients, sent to him by
plane, from all over the United States.
At the time of the war in Algeria, with injured people
that often were highly infected, at Necker, we accepted pa-
tients coming from all over France, from Algeria and even
from Chad, as the French Military Health Services and So-
cial Security paid their transport and treatment. It’s inter-
esting to see how social policy is involved in the
implementation of treatments. Through French social pol-
icy, in Paris, then quickly in Lyon and Toulouse, and after
everywhere in France, we have gained experience with
these patients. I will not discuss further but to say that,
three years later in 1957, I went to South America to
install the first artificial kidney in Sao Paulo, because there
was a South American student who spent some time with
us at Necker.
And you will find the same problem during develop-
ment of renal biopsy. There comes a time, when you
want to get ahead and get right down to applying a new
observation, a new treatment, where patients must be
grouped together so that you know immediately how to
get and interpret the results.
At that time, the artificial kidney, the treatment of acute
kidney injury by dialysis, was the basis of the principle of
intensive care. I’ll show you a book on intensive care that
I published with Hamburger and Crosnier, which we
wrote in September ‘52, which was printed in March ‘54
by Flammarion; it was the first book about intensive care,
the gateway to the intensive care unit (ICU).
And so, that’s why we started with this. After I’ll tell
you why we abandoned it.
Why did we start with this? Because returning from
the summer holidays in 1952, we sat down and reviewed
what had happened in the previous months. We did not
yet have the artificial kidney, we had in mind that there
were other diseases than renal diseases that were poten-
tially life-threatening, but possibly reversible.
Hamburger and I were driving to visit a patient at
the American Hospital of Paris, and we were cross-
ing the Bois de Boulogne; it was the usual route,
and during this trip, we did not need to pay atten-
tion to the .... Hamburger said, “Well, we may
organize a day or two dedicated to intensive care,
but should we continue following this path or give
up?”.
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He asked me the question, and I said “Why not? Let’s
continue.” We talked again a few days later and he said:
“We should stop, because you should never have two
goals in life,” and I told him that when I was in the
French commando unit, an older lieutenant told me: “If
you have two goals, you’ll reach none and there is a high
risk of being killed. No second goal.”.
(…)
Now let’s finish with the case of Marius Renard.
Marius Renard, his name tells you nothing. But, on
December 18th, 1952, Marius Renard, who lived in a
small village 60 km North of Paris, near Beauvais,
was an apprentice roofer who fell from a roof three
stories high on his right kidney, which ruptured, so
the surgeon removed it, because he had huge
hematuria and became anuric.
What the surgeon did not know was that this poor kid
had only one functioning kidney. He was taken to Paris,
Necker; the urologists referred him to us because they
did not know what to do. His mother proposed to do-
nate one of her kidneys because she had seen a movie
where there was supposedly a kidney transplant.
You must take into account all the social life factors
as well as all new developments in medicine.
The mother had almost all blood groups, and all
subgroups identical to those of her son and a kidney
transplant was carried out on December 25th, 1952 at
9 pm at the Necker Hospital in Paris. A few days
later, the news spread in the press, we’ll see later; the
kidney worked, but the glomerular filtration was
never very good.
The urea clearance was 25 ml and dropped dramatic-
ally to 18 ml 20 days after transplantation, and then it
stopped suddenly. We re-operated to find out if there
was not a surgical complication, but there was nothing
to do, and death came.
And with this story we had three conclusions: first,
there was the HLA system that we did not know about
yet, Dausset was just beginning his work. There were
small differences in subgroups; it was intellectually the
same as a crash incompatibility transfusion.
Secondly, there were a number of small signs: the
kidney became a little bigger, blood pressure mea-
sured every hour rose 5 mm during the last two days,
from the 19th to 20th day. There was another small
sign; there was a trace of albumin in the urine, which
did not exist before. Therefore, there were all the
clinical signs, which lead to the diagnosis of rejection,
which we described at this time.
Third, there was a global social impact. Marius
died; at his funeral, in his village, 50 m of street were
blocked by flowers coming from all over the world ...
All over the world people sent telegrams. Some said
they were ready to donate a kidney to attempt a
second transplant for Marius. As a consequence, you
know, the world public opinion told Medicine: “Find
a solution for kidney transplants.”.
And it is always thinking about well-observed
unique cases, which makes us progress in medicine.
The institution “Assistance Publique-Hôpitaux de
Paris” immediately considered the Nephrology de-
partment of Necker as the place where it was neces-
sary to do renovation work, and we went from 40 to
100 square meters, and further. And seven years
later, in ‘59, there was the Merrill transplantation
technique, followed by the Hamburger’s transplant-
ation, but at that time I was just a witness and no
longer an actor.
That’s what I can tell you about how amazing this
story was ... it’s necessary to have an educated mind,
but with an education that has not demolished the
thinking process. If I only told you that, and if you
let yourselves be seduced by the old man that I am,
do read “The Thibaults” which has 3000 pages ...
(…)
Choosing medicine? That doesn’t mean specifically
nephrology, I would tell a student: “Choose a branch
that you love; to love it, you must know it, therefore,
you must have measured its past and its future po-
tentials, you must simultaneously conduct a creative
scientific work, but animated, nourished by a med-
ical culture”.
We are doctors to heal, period.
If we do not have a healing goal, we only make
beautiful literature, but I leave this to others. What is
stupid, profoundly stupid in our medical profession, is
to believe that because you are protected by a power-
ful university, you become important. In this case,
that kind of importance is nonsense. You can write it;
I do not mind.
Does poetry exist in our medical profession? Well, I
do not know; (…) because in poetry you need to read
verses, or to express your thought with delicacy and
strength ...
But I know that without a heart, medicine does not
exist.
Computer medicine? it’s not possible. It’s just like
Justice. Why are there still judges and not just com-
puters? It is because there are things you can’t put in
a computer.
A doctor is someone who decides; when he writes,
he writes a prescription, this means he prescribes
and takes responsibility.
Is it possible to give a prescription and decide regard-
less of compassion? Unfortunately, I know that many do
not share my idea, but that’s life.....
I am like the Queen of Holland, whose motto is: “I will
maintain!”
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Professor Gabriel Richet: A synopsis of his life and
achievements
Gabriel Richet was born in 1916 in Paris, from a bril-
liant dynasty of physicians: his father, Charles Richet
junior, was a specialist in human nutrition, Professor
at the Faculty of Medicine in Paris. His mother,
Marthe Trélat was one of the first women who be-
came interne (resident) in the hospitals of Paris. His
grandfather, Charles Richet, was a Nobel laureate in
1913, for the discovery of anaphylaxis.
During the Second World War, he participated in the
Campaign of France in 1940 and in the combats in the
Vosges Mountains in 1945 where he was wounded. He
was a decorated World War Two veteran and received
the award of “Chevalier de la Légion d’Honneur” by Gen-
eral de Gaulle in Karlsruhe in April 1945.
From 1950 to 1960 he was with Jean Hamburger, the
founder of French and international Nephrology, at
Necker Hospital in Paris; both are considered belonging
to the post-war rebuilders of the French academic
medicine.
After having spent three months in Boston in the depart-
ment of nephrology directed by John Merrill, he realized
the first hemodialysis in France and was involved in the first
allogenic transplantation that was not immediately rejected.
Together with Jean Hamburger and Jean Crosnier, he de-
veloped the concept of renal intensive care aimed at cor-
recting disorders of the major fluid electrolyte, acid-base,
and other metabolic functions, thereby markedly improving
the prognosis of patients with acute kidney injury.
In 1961, he founded the nephrology service at Tenon
Hospital and attracted in his clinical department as well as
in his research laboratory, many young collaborators, and
scientists. Among his pivotal contributions, was the
characterization, with Jacqueline Hagège and Manfred
Gabe, of the dark cells (intercalated cells) of the collecting
duct, which play a key role in acid-base regulation. He was
also, with his group, a founder of translational medicine
long before this name was coined, bringing to the lab un-
usual cases and conversely translating into clinical applica-
tions the results obtained in experimental models.
He was a founding member of the International Soci-
ety of Nephrology (ISN) in 1960, and President of the
ISN between 1981 and 1984.
After his retirement in 1985, he remained an active
member of the French Academy of Medicine and de-
voted much of his time to the history of medicine and,
particularly, of nephrology.
He received numerous honors and awards, including
honoris causa degrees, and the prestigious Jean Hamburger
award of the International Society of Nephrology in 1993.
In 2012, he was appointed Grand Officier de la Légion
d’honneur of France, one of the highest honors of the
French Republic (Figs. 2, 3 and 4).
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